Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (41-50 of 271) with videos related to

Pageof 28
Sort By:
Current Oncology Reports|September 4, 2008
Current status of debulking nephrectomy in the era of tyrosine kinase inhibitorsVitaly Margulis, Christopher G Wood, Eric Jonasch, et al.
Chinese Journal of Cancer|December 15, 2012
Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic featuresKanishka Sircar, Priya Rao, Eric Jonasch, et al.
Seminars in Oncology|June 9, 2020
Chronic hepatitis C virus infection and genitourinary cancers: A case-control studyGeorgios Angelidakis, Parag Mahale, Eric Jonasch, et al.
Human Pathology|August 2, 2014
Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 casesPriya Rao, Federico Monzon, Eric Jonasch, et al.
Clinical Genitourinary Cancer|May 4, 2025
Disease Monitoring and Treatment Patterns of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United StatesEric Jonasch, Yan Song, Jonathan Freimark, et al.
Oncotarget|February 9, 2017
Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinomaPavlos Msaouel, Amado J Zurita, Shixia Huang, et al.
Cancer|February 26, 2009
Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measuresElizabeth R Plimack, Nizar Tannir, E Lin, et al.
BJU International|May 20, 2008
Patterns of intervention for renal lesions in von Hippel-Lindau diseaseSurena F Matin, Kamran Ahrar, Christopher G Wood, et al.
Hereditary Cancer in Clinical Practice|April 21, 2026
Monitoring and treatment patterns of von Hippel-Lindau disease-associated central nervous system hemangioblastomasEric Jonasch, Yan Song, Jonathan Freimark, et al.
Journal of Extracellular Vesicles|March 27, 2023
The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cellsSong Yi Ko, WonJae Lee, Melanie Weigert, et al.
Pageof 28

Showing results (41-50 of 271) with videos related to

Sort By:
Pageof 28
Current Oncology Reports|September 4, 2008
Current status of debulking nephrectomy in the era of tyrosine kinase inhibitorsVitaly Margulis, Christopher G Wood, Eric Jonasch, et al.
Chinese Journal of Cancer|December 15, 2012
Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic featuresKanishka Sircar, Priya Rao, Eric Jonasch, et al.
Seminars in Oncology|June 9, 2020
Chronic hepatitis C virus infection and genitourinary cancers: A case-control studyGeorgios Angelidakis, Parag Mahale, Eric Jonasch, et al.
Human Pathology|August 2, 2014
Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 casesPriya Rao, Federico Monzon, Eric Jonasch, et al.
Clinical Genitourinary Cancer|May 4, 2025
Disease Monitoring and Treatment Patterns of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United StatesEric Jonasch, Yan Song, Jonathan Freimark, et al.
Oncotarget|February 9, 2017
Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinomaPavlos Msaouel, Amado J Zurita, Shixia Huang, et al.
Cancer|February 26, 2009
Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measuresElizabeth R Plimack, Nizar Tannir, E Lin, et al.
BJU International|May 20, 2008
Patterns of intervention for renal lesions in von Hippel-Lindau diseaseSurena F Matin, Kamran Ahrar, Christopher G Wood, et al.
Hereditary Cancer in Clinical Practice|April 21, 2026
Monitoring and treatment patterns of von Hippel-Lindau disease-associated central nervous system hemangioblastomasEric Jonasch, Yan Song, Jonathan Freimark, et al.
Journal of Extracellular Vesicles|March 27, 2023
The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cellsSong Yi Ko, WonJae Lee, Melanie Weigert, et al.
Pageof 28